Novel strategies and therapeutic options for the management of primary biliary cholangitis
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease. It has a varied course of progression ranging from being completely asymptomatic to aggressive disease leading to cirrhosis and resulting in liver transplantation. In addition, symptoms can be debilitating and can have a major...
Main Authors: | Amardeep Khanna, David E. Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-10-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X17728669 |
Similar Items
-
Update on Emerging Treatment Options for Primary Biliary Cholangitis
by: Aguilar MT, et al.
Published: (2020-05-01) -
Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
by: Dong-Won Ahn
Published: (2020-05-01) -
Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial
by: Amardeep Khanna, et al.
Published: (2018-04-01) -
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
by: Ji-Won Park, et al.
Published: (2022-05-01) -
Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management
by: Aditi Kumar, et al.
Published: (2016-06-01)